UNIVERSITE DE ROUEN NORMANDIE;CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人:
Bruno José GONZALEZ,Stéphane MARRET,Matthieu Jean Alexandre LECUYER,Annie LAQUERRIERE,Soumeya BEKRI,Céline LESUEUR,Sylvie Marguerite Alberte JEGOU,Pascale Yvonne Joséphine MARCORELLES
申请号：
US16465465
公开号：
US20190351018A1
申请日:
2017.12.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to a placental growth factor (PlGF) to be used as a drug in the prevention and/or treatment of fetal alcohol syndrome disorders (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcohol in utero. The invention also relates to a pharmaceutical composition or a product comprising the PlGF for the same therapeutic uses.
